CINCLUS PHARMA HOLDING AB revenue breakdown overview

CINCLUS PHARMA HOLDING AB revenue for the last year amounted to 27.50 M SEK, the most of which — 5.96 M SEK — came from its highest performing source at the moment, Clinical Stage Drug for Gastric Acid Related Diseases, the year earlier bringing 10.57 M SEK. The greatest contribution to the revenue figure was made by China — last year it brought CINCLUS PHARMA HOLDING AB 5.96 M SEK, and the year before that — 10.57 M SEK.